← Back to all trials
Not Yet Recruiting
NCT07638111
SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level
Conditions: Obesity & Overweight, Insulin Resistance Syndrome
Sex: All
Ages: 18 Years – 50 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 20
Sponsor: Hospices Civils de Lyon
Location: Centre de Recherche en Nutrition Humaine Rhône-Alpes, Centre Hospitalier Lyon Sud Pierre-Bénite
Summary
This single-center, randomized, single-blind, 2-period crossover interventional study will evaluate whether exposure to a pleasant food odor 10 minutes before a 75 g oral glucose tolerance test (OGTT) modifies glucose homeostasis in adults with different metabolic phenotypes. Participants will undergo two experimental conditions in random order: food odor stimulation and control condition without odor, separated by a 4-week washout. The main objective is to quantify the within-subject effect of food odor stimulation on the incremental area under the glucose curve (iAUC) from 0 to 120 minutes during OGTT and to assess whether this effect differs according to metabolic status. Two predefined groups will be enrolled: adults without overweight and without insulin resistance, and adults with class I obesity and low-to-moderate insulin resistance. Secondary objectives include characterization of cephalic phase insulin release (CPIR), C-peptide and GLP-1 responses, glycemic kinetics, associations between CPIR and metabolic responses, and participant acceptability of the test environment and olfactory stimulation. A plasma biobank will be constituted from part of the collected samples for future research.
Eligibility Criteria
Inclusion Criteria
* Age 18 to 50 years inclusive
* Stable body weight during the previous 3 months (±5% of total body weight)
* Willing to comply with the full study protocol
* Sedentary lifestyle or stable regular physical activity, with agreement to keep this unchanged throughout the study
* Able to understand study information, read and write French, and provide written informed consent
* Affiliated with a social security scheme or equivalent
* Non-smoker and non-vaper
* Willing not to take dietary supplements, probiotics, prebiotics, or laxatives for 10 days before each visit
* For women of childbearing potential: negative serum pregnancy test; not pregnant and not breastfeeding
* Mean score between 1 and 2 on the 3 specific CiTAS questionnaire statements used as inclusion criteria
* ETOC flash olfactory screening: able to detect the odor-containing vial among 4 presented vials for all 7 odors tested
* Able to identify the madeleine odor used in the study
* Rated pleasantness/appetence of the madeleine odor above 1/9
* For the no-overweight group: BMI 19 to \
Source: ClinicalTrials.gov (NCT07638111). StuddyBuddy aggregates publicly available trial information.